Aperio Group LLC raised its stake in HealthEquity, Inc. (NASDAQ:HQY) by 28.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 12,773 shares of the company’s stock after buying an additional 2,806 shares during the period. Aperio Group LLC’s holdings in HealthEquity were worth $636,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also modified their holdings of the company. Louisiana State Employees Retirement System raised its position in shares of HealthEquity by 1.1% in the second quarter. Louisiana State Employees Retirement System now owns 18,100 shares of the company’s stock valued at $902,000 after buying an additional 200 shares during the last quarter. Exane Derivatives acquired a new position in shares of HealthEquity during the second quarter valued at $132,000. State of Alaska Department of Revenue raised its position in shares of HealthEquity by 80.4% in the second quarter. State of Alaska Department of Revenue now owns 8,748 shares of the company’s stock valued at $435,000 after buying an additional 3,898 shares during the last quarter. Creative Planning raised its position in shares of HealthEquity by 94.4% in the second quarter. Creative Planning now owns 3,274 shares of the company’s stock valued at $163,000 after buying an additional 1,590 shares during the last quarter. Finally, Narus Financial Partners LLC acquired a new position in shares of HealthEquity during the second quarter valued at $222,000. Institutional investors own 90.54% of the company’s stock.
Shares of HealthEquity, Inc. (NASDAQ HQY) traded down 1.76% during mid-day trading on Wednesday, hitting $42.39. The stock had a trading volume of 155,074 shares. The company’s 50 day moving average price is $47.72 and its 200 day moving average price is $46.02. The stock has a market cap of $2.54 billion, a P/E ratio of 79.68 and a beta of 1.73. HealthEquity, Inc. has a 12-month low of $28.59 and a 12-month high of $54.95.
HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, June 6th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.03. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. The business had revenue of $55.40 million for the quarter, compared to analyst estimates of $54.77 million. During the same period last year, the business posted $0.15 EPS. HealthEquity’s revenue was up 25.9% compared to the same quarter last year. Equities research analysts predict that HealthEquity, Inc. will post $0.58 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this news story on another site, it was copied illegally and reposted in violation of United States and international trademark and copyright laws. The correct version of this news story can be viewed at https://stocknewstimes.com/2017/08/23/aperio-group-llc-has-636000-stake-in-healthequity-inc-hqy.html.
A number of research analysts have commented on the company. Zacks Investment Research cut HealthEquity from a “buy” rating to a “hold” rating in a research note on Friday, August 4th. BidaskClub cut HealthEquity from a “hold” rating to a “sell” rating in a research note on Thursday, August 3rd. TheStreet upgraded HealthEquity from a “c” rating to a “b” rating in a research note on Monday, July 31st. Cantor Fitzgerald upped their price target on HealthEquity from $55.00 to $56.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 5th. Finally, Oppenheimer Holdings, Inc. restated an “outperform” rating and set a $61.00 price target (up from $57.00) on shares of HealthEquity in a research note on Monday, June 12th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $50.22.
In other HealthEquity news, major shareholder Berkley Capital, Llc sold 248,351 shares of the stock in a transaction on Tuesday, June 13th. The shares were sold at an average price of $52.80, for a total value of $13,112,932.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Stephen Neeleman sold 8,500 shares of the stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $46.65, for a total transaction of $396,525.00. Following the completion of the sale, the insider now directly owns 1,000 shares of the company’s stock, valued at $46,650. The disclosure for this sale can be found here. Insiders sold a total of 2,449,321 shares of company stock worth $125,721,793 over the last quarter. 19.00% of the stock is currently owned by company insiders.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY).
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
